Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 77 clinical trials
Shandong Cancer Hospital Affiliated to Shandong University

In this study,the eligible breast cancer patients will be randomized divided into two groups. the study group receive the accelerated hypo-fractioned whole breast irradiation with a concurrent boost to the tumor bed (WBI 2.5Gy x18 and SIB 2.88Gy x18) and the control group receive conventional fractioned whole breast irradiation with …

invasive breast cancer
whole breast irradiation
cancer
breast conserving surgery
breast cancer
  • 4 views
  • 25 Feb, 2022
  • 1 location
Feasibility Study of Intraoperative Detection of Residual Cancer in Breast Cancer Patients

This is a prospective, multi-center, two-arm, randomized, clinical trial evaluating patients undergoing breast conserving surgery using the LUM Imaging System.

ductal carcinoma in situ
mammogram
breast carcinoma
lumpectomy
ductal carcinoma
  • 0 views
  • 04 Oct, 2022
  • 3 locations
Hemopatch Versus Axillary Drainage After Axillary Lymphadenectomy

Aspirative drainage continues to be the "gold standard" for the management of this post-surgical complication, even though it can lead to complications such as obstruction of the drainage, peritubal leakage of the seroma, etc. This may result in pain and reduction in mobility of the affected arm. Based on our …

axillary lymph node dissection
cancer
seroma
lymph node dissection
cancer surgery
  • 10 views
  • 16 Sep, 2021
  • 1 location
Whole Breast + Lymph Node Irradiation: Prone Compared to Supine Position in 15 or 5 Fractions

for breast cancer patients receiving whole breast and regional nodal irradiation after breast conserving surgery.

immunostimulant
breast cancer
breast-conserving surgery
cancer
  • 10 views
  • 22 Jan, 2021
  • 1 location
Evaluating Mass Spectrometry And Intraoperative MRI In The Advanced Multimodality Image Guided Operating Suite (Amigo) In Breast-Conserving Therapy

The purpose of this study is to investigate the use of intra-operative Magnetic Resonance Imaging (MRI) and Mass Spectrometry (MS) during breast conserving surgery, and to determine if these

mammogram
breast tumor
breast-conserving surgery
  • 0 views
  • 22 Mar, 2022
  • 1 location
Super Hypofractionated Irradiation For Whole Breast Treatment (SHIFT)

The purpose of this trial is to investigate the safety and efficacy of super hypofractionated whole breast irradiation (SHF-WBI) in breast cancer patients treated with breast conserving surgery

ductal carcinoma in situ
metastasis
HER2
epidermal growth factor receptor
ki-67
  • 0 views
  • 04 Oct, 2022
  • 1 location
DFS and QOL After Modified Radical Mastectomy vs. Expanded Mckissock Surgery for EIC of the Breast

radiotherapy. Mckissock surgery was applied in breast-conserving surgery for breast cancer in 2016. Jianyi Li and the team members (Shengjing Hospital of China Medical University, Shenyang, China) applied this

ductal carcinoma in situ
cancer
ductal carcinoma
carcinoma
breast cancer
  • 1 views
  • 26 Mar, 2022
  • 3 locations
A Comparative Study of Pravastatin vs Placebo as Primary Prevention of Severe Subcutaneous Breast Fibrosis in Hyper-radiosensitive Identified Patients With Breast Cancer (PRAVAPREV-01)

that will offer a personalised strategy to breast cancer patients who will be treated with adjuvant RT after breast conserving surgery: By assessing individual risk of severe RIF

carcinoma
invasive carcinoma
breast-conserving surgery
  • 0 views
  • 21 Mar, 2022
  • 7 locations
Magnetic Occult Lesion Localization Instrument (MOLLI) Guidance System for Breast Lesion Localization

Instrument (MOLLI), an approved instrument for Breast Conserving Surgery (BCS) in patients with non-palpable lesions. All patients who have an area of concern in the breast and are identified by their

ductal carcinoma
mammogram
carcinoma
breast-conserving surgery
  • 2 views
  • 05 Oct, 2021
  • 1 location
Evaluating Harms and Benefits of Endocrine Therapy in Patients ≥70 Years of Age With Lower Risk Breast Cancer

The current standard of care for stage 1 hormone receptor-positive (HR+) breast cancer consists of breast-conserving surgery followed by adjuvant radiotherapy (RT) and endocrine therapy (ET) for

breast carcinoma
progesterone receptor
HER2
carcinoma
estrogen
  • 0 views
  • 07 Oct, 2022
  • 1 location